Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Stomach”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03141034
What this trial is testing

Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Washington University School of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT06419140
What this trial is testing

Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 138
Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Large-scale testing (Phase 3)Study completedNCT03081143
What this trial is testing

Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

Who this might be right for
Advanced Gastric or EGJ Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 429
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Testing effectiveness (Phase 2)Looking for participantsNCT07178808
What this trial is testing

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Who this might be right for
Gastric Adenocarcinoma
Banner Health 30
Large-scale testing (Phase 3)UnknownNCT05978050
What this trial is testing

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd. 354
Testing effectiveness (Phase 2)Study completedNCT00054873
What this trial is testing

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsAdenocarcinoma
Chiron Corporation
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802288
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as Perioperative Therapy for Resectable Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 80
Testing effectiveness (Phase 2)UnknownNCT03451942
What this trial is testing

The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

Who this might be right for
Adenocarcinoma of the Stomach / Gastroesophageal
Henan Cancer Hospital 112
Testing effectiveness (Phase 2)Ended earlyNCT05207722
What this trial is testing

CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

Who this might be right for
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Celularity Incorporated 1
Not applicableNot Yet RecruitingNCT07438418
What this trial is testing

An Observational Study on Gastric Cancer in High-risk Individuals

Who this might be right for
Gastric Adenocarcinoma
Fudan University 3,000
Not applicableLooking for participantsNCT07660627
What this trial is testing

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Who this might be right for
Esophageal AdenocarcinomaGastric CancerPancreatic Cancer
Masaryk Memorial Cancer Institute 34
Testing effectiveness (Phase 2)Ended earlyNCT02016534
What this trial is testing

Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

Who this might be right for
Stomach Neoplasms
Amgen 60
Testing effectiveness (Phase 2)UnknownNCT01880632
What this trial is testing

Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Shanghai Zhongshan Hospital 55
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Testing effectiveness (Phase 2)UnknownNCT00075465
What this trial is testing

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach

Who this might be right for
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT01020630
What this trial is testing

Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 91
Testing effectiveness (Phase 2)Study completedNCT03472365
What this trial is testing

SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 67
Next Page